NOVAVAX INC: change in inventories
Change in inventories for NOVAVAX INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All NOVAVAX INC financial histories
What this measure means
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
Exact concept: us-gaap:IncreaseDecreaseInInventories. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-01-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 3,240,000 | USD | 2026-02-26 | 10-K · 0001000694-26-000007 |
| 2024-01-01 | 2024-12-31 | -12,914,000 | USD | 2026-02-26 | 10-K · 0001000694-26-000007 |
| 2023-01-01 | 2023-12-31 | 74,457,000 | USD | 2026-02-26 | 10-K · 0001000694-26-000007 |
| 2022-01-01 | 2022-12-31 | 477,801,000 | USD | 2025-02-27 | 10-K · 0001000694-25-000004 |
| 2021-01-01 | 2021-12-31 | 8,872,000 | USD | 2024-02-28 | 10-K · 0001000694-24-000007 |
| 2020-01-01 | 2020-12-31 | 0 | USD | 2023-02-28 | 10-K · 0001000694-23-000005 |
Related financial histories
- NOVAVAX INC: total assets
- NOVAVAX INC: total liabilities
- NOVAVAX INC: stockholders equity
- NOVAVAX INC: cash and cash equivalents
- NOVAVAX INC: net income or loss
- NOVAVAX INC: operating cash flow
- NOVAVAX INC: revenue
- NOVAVAX INC: contract revenue excluding tax
- NOVAVAX INC: financing cash flow
- NOVAVAX INC: investing cash flow
- NOVAVAX INC: retained earnings or deficit
- NOVAVAX INC: basic weighted-average shares
- NOVAVAX INC: diluted weighted-average shares
- NOVAVAX INC: basic earnings per share
- NOVAVAX INC: diluted earnings per share
- NOVAVAX INC: income tax expense or benefit
- NOVAVAX INC: net property, plant and equipment
- NOVAVAX INC: share-based compensation expense
- NOVAVAX INC: operating income or loss
- NOVAVAX INC: current assets
- NOVAVAX INC: interest expense
- NOVAVAX INC: current liabilities
- NOVAVAX INC: current accounts payable
- NOVAVAX INC: goodwill carrying amount
- NOVAVAX INC: net finite-lived intangible assets
- NOVAVAX INC: net current accounts receivable
- NOVAVAX INC: net inventory
- NOVAVAX INC: cost of revenue
- NOVAVAX INC: selling, general and administrative expense
- NOVAVAX INC: research and development expense
- NOVAVAX INC: common shares outstanding
- NOVAVAX INC: cash including restricted cash
- NOVAVAX INC: additional paid-in capital
- NOVAVAX INC: accumulated other comprehensive income or loss
- NOVAVAX INC: operating lease right-of-use asset
- NOVAVAX INC: operating lease liability
- NOVAVAX INC: gross property, plant and equipment
- NOVAVAX INC: accumulated depreciation on property, plant and equipment
- NOVAVAX INC: net intangible assets excluding goodwill
- NOVAVAX INC: other noncurrent assets
- NOVAVAX INC: other noncurrent liabilities
- NOVAVAX INC: accrued current liabilities
- NOVAVAX INC: prepaid expenses and other current assets
- NOVAVAX INC: current contract liabilities
- NOVAVAX INC: net deferred tax assets
- NOVAVAX INC: pre-tax income or loss from continuing operations
- NOVAVAX INC: comprehensive income or loss
- NOVAVAX INC: net income available to common stockholders
- NOVAVAX INC: general and administrative expense
- NOVAVAX INC: depreciation, depletion and amortization
- NOVAVAX INC: amortization of intangible assets
- NOVAVAX INC: nonoperating interest expense
- NOVAVAX INC: other nonoperating income or expense
- NOVAVAX INC: current income tax expense or benefit
- NOVAVAX INC: deferred income tax expense or benefit
- NOVAVAX INC: interest paid, net
- NOVAVAX INC: income taxes paid, net
- NOVAVAX INC: proceeds from issuing common stock
- NOVAVAX INC: operating lease payments
- NOVAVAX INC: change in accounts receivable
Inspect the source
- Entity
- NOVAVAX INC / CIK 0001000694
- Captured
- 2026-09-19T11:15:37.615Z
- SEC response SHA-256
0fb56a11efd6cc96d61f018dff603b80c35a0c72f25cb72fbb22841851b792af
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001000694.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))